Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Cash from Financing Activities (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed Cash from Financing Activities for 14 consecutive years, with $2.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 94.22% to $2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, down 95.2% year-over-year, with the annual reading at $2.6 million for FY2025, 95.2% down from the prior year.
  • Cash from Financing Activities hit $2.6 million in Q4 2025 for Cardiff Oncology, up from $25000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $44.2 million in Q4 2024 to a low of $3000.0 in Q1 2025.
  • Historically, Cash from Financing Activities has averaged $8.4 million across 4 years, with a median of $2.1 million in 2024.
  • Biggest five-year swings in Cash from Financing Activities: dropped 15.57% in 2021 and later tumbled 99.66% in 2025.
  • Year by year, Cash from Financing Activities stood at $15.0 million in 2021, then crashed by 99.5% to $75000.0 in 2022, then soared by 58817.33% to $44.2 million in 2024, then crashed by 94.22% to $2.6 million in 2025.
  • Business Quant data shows Cash from Financing Activities for CRDF at $2.6 million in Q4 2025, $25000.0 in Q3 2025, and $3000.0 in Q1 2025.